Stronger Sell Today AMPH ranks #4142 as SELL CANDIDATE. Weaker Sell
Today AMPH ranks #4142 as SELL CANDIDATE.

AMPH stock Amphastar Pharmaceuticals

AMPH stock
Amphastar Pharmaceuticals

March 19, 2019
Change 1.18%
Chart period: 2018-12-20 - 2019-03-19





Will AMPH stock price go up or down on Thu, 21 Mar 2019?

Amphastar Pharmaceuticals Forecast and Stock Analysis

Technical AMPH stock analysis for March 19, 2019.

Sell candidate since 2019-03-13 Loss -0.34%
Shorts n/a
Cash n/a
Loans n/a
Beta 1.35
ROA -1.19

Amphastar Pharmaceuticals gained 1.18% in the last trading day, rising from $20.37 to $20.61 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 7 of the last 10 days and is down by -16.66% for this period. Volume fell in the last day by -53 107 shares, and in total, 205 208 shares bought and sold for approximately $4.23 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Tuesday, 19th Mar 2019) of the AMPH stock was $20.61. This is 1.18% more than the trading day before Monday, 18th Mar 2019.

During day the stock fluctuated 1.32% from a day low at $20.49 to a day high of $20.76.

30 day high of the AMPH stock price was $25.43 and low was $19.70.
90 day high was $25.43 and low was $18.89.
52 week high for the Amphastar Pharmaceuticals - $25.43 and low - $14.40.


Amphastar Pharmaceuticals lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $20.35 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 15.82% during the next 3 months and, with 90% probability hold a price between $23.57 and $30.12 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Friday March 15, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Amphastar Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $21.47 and $23.29. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 23 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Amphastar Pharmaceuticals finds support from accumulated volume at $20.50.

Support: $20.50 Price: $20.61 Resistance: $20.68


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.27 between high and low, or 1.32%. For the last week, the stock has had a daily average volatility of 4.44%.

Amphastar Pharmaceuticals is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

The Amphastar Pharmaceuticals stock holds several negative signals and despite the positive trend we believe Amphastar Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Stronger Sell Today AMPH ranks #4142 as SELL CANDIDATE. Weaker Sell
Today AMPH ranks #4142 as SELL CANDIDATE.